The 12 references in paper E. Sakanyan I., T. Shemeryankina B., Yu. Malkina K., M. Lyakina N., N. Postoyuk A., Е. Саканян И., Т. Шемерянкина Б., Ю. Малкина К., М. Лякина Н., Н. Постоюк А. (2018) “Современные подходы к оценке эффективности и безопасности лекарственных средств растительного происхождения в России и за рубежом // Modern approaches to herbal preparations efficacy and safety assessment in Russia and abroad” / spz:neicon:vedomostincesmp:y:2015:i:1:p:35-39

1
General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Geneva: WHO; 2000. Available from: http://apps.who.int/ medicinedocs/en/d/Jwhozip42e/.
(check this in PDF content)
2
Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines. Manila: WHO Regional office for the Western Pacific; 1993. Available from: http:// whqlibdoc.who.int/wpro/-1993/9290611103.pdf.
(check this in PDF content)
3
Directive 2001/83/ЕС of the European Parliament and of the Council of 6 November 2001 on the Community Code relating to Medicinal Products for Human Use with amendments. Official Journal L–311, 28.11.2004; 67-128.
(check this in PDF content)
4
Directive 2004/24/EC of the European Parliament and the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal L–136, 30.04.2004; 85–90.
(check this in PDF content)
5
European Medicines Agency. Available from: http://www.ema.europa.eu/ ema/index.jsp?curl=pages/regulation/general/general_content_000208. jsp.
(check this in PDF content)
6
Guideline on the assessment of clinical safety and efficacy in the preparation of community herbal monographs for well-established and of community herbal monographs/entries to the community list for traditional herbal medical products/substances/preparations. London, 7 September 2006. Doc. Ref. EMEA/HMPC/104613/2005. Available from: http://www.ema. europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/ WC500003644.pdf.
(check this in PDF content)
7
Guideline on clinical assessment of fixed combination of herbal substances/ herbal preparations. London, 11 January 2006. Doc. Ref. EMEA/ HMPC/166326/2005. Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/Scientific_guideline/2009/09/WC500003645. pdf
(check this in PDF content)
8
Methodical instructions on the procedure for pre-clinical and clinical study of drugs of natural origin and homeopathic medicines. Ministry of Health and Medical Industry of the Russian Federation, Office of the State quality control of medicines and medical equipment. Moscow; 1994.
(check this in PDF content)
9
Mironov AN, ed. Guidelines for pre-clinical trials of drugs. Part I. Moscow: Grif i K; 2012.
(check this in PDF content)
10
Lesiovskaya EE, Verstakova OL, Arzamastsev EV, Paskhina OE, et al. Criteria for assessing the efficacy and safety of herbal drugs on the stage of pre-clinical trials and pre-registration pharmaco-toxicological examination. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya 2007; (4): 77–83.
(check this in PDF content)
11
Krepkova LV, Bortnikova, Sokolskaya TA. Some aspects of the toxicological study of drugs based on medicinal plants. Fundamentalnye issledovaniya 2013; 9(2): 256–8. Available from: www.rae.ru/ fs/?section=content&op=show_article&article_id=10001465.
(check this in PDF content)
12
Habriev RU, ed. Guidelines for clinical trials of new drugs. Moscow: Meditsina; 2005. R E F E R E N C E S Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, 8 Petrovsky
(check this in PDF content)